WLK WESTLAKE CORP
Industrial Organic Chemicals · NYSE · SEC CIK 1262823 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.4%
TTM net income YoY53.3%
TTM EPS YoY53.2%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—
Margins
Gross margin10.8%
Operating margin-3.8%
Net margin-3.9%
FCF margin0.1%
EBITDA margin6.3%
Returns
ROE-4.9%
ROA-2.3%
ROIC (approx.)-2.9%
Asset turnover0.59x
Leverage & solvency
Liabilities / assets52.5%
Debt / equity0.58x
Current ratio2.38x
Interest coverage-2.04x
Cash quality & payout
Operating cash flow / net income-1.89x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue7.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $11.17B | $12.14B | $12.55B | $15.79B | $11.78B |
| Cost of revenue | $10.36B | $10.19B | $10.33B | $11.72B | $8.28B |
| Gross profit | $813.00M | $1.96B | $2.22B | $4.07B | $3.50B |
| SG&A expense | $900.00M | $874.00M | $865.00M | $835.00M | $551.00M |
| Operating income | -$1.58B | $875.00M | $729.00M | $3.05B | $2.80B |
| Interest expense | $171.00M | $159.00M | $165.00M | $177.00M | $176.00M |
| Pretax income | -$1.60B | $938.00M | $700.00M | $2.95B | $2.68B |
| Income tax | -$126.00M | $291.00M | $178.00M | $649.00M | $607.00M |
| Net income | -$1.51B | $602.00M | $479.00M | $2.25B | $2.02B |
| EBITDA | -$400.00M | $1.99B | $1.83B | $4.11B | $3.64B |
| EPS (basic) | -11.70 | 4.66 | 3.73 | 17.46 | 15.66 |
| EPS (diluted) | -11.70 | 4.64 | 3.70 | 17.34 | 15.58 |
| Dividends declared per share | 2.11 | 2.05 | 1.71 | 1.31 | 1.14 |
| Weighted avg. shares (diluted) | 128.26M | 129.21M | 128.60M | 128.85M | 128.70M |
| Balance sheet | |||||
| Cash & equivalents | $2.72B | $2.94B | $3.32B | $2.25B | $1.94B |
| Short-term investments | $204.00M | $0 | — | — | — |
| Receivables | $1.23B | $1.31B | $1.39B | $1.65B | $1.74B |
| Inventory | $1.65B | $1.70B | $1.62B | $1.87B | $1.41B |
| Current assets | $6.22B | $6.21B | $6.61B | $5.97B | $5.26B |
| PP&E, net | $8.61B | $8.63B | $8.52B | $8.48B | $7.61B |
| Goodwill | $1.31B | $2.03B | $2.04B | $2.16B | $2.02B |
| Intangibles | $743.00M | $820.00M | $910.00M | $993.00M | $1.08B |
| Total assets | $19.96B | $20.75B | $21.04B | $20.55B | $18.46B |
| Current liabilities | $2.77B | $2.22B | $2.79B | $2.30B | $2.34B |
| Short-term debt | $497.00M | $6.00M | $299.00M | $0 | $269.00M |
| Long-term debt | $5.09B | $4.56B | $4.61B | $4.88B | $4.91B |
| Total debt | $5.58B | $4.56B | $4.91B | $4.88B | $5.18B |
| Total liabilities | $10.67B | $9.71B | $10.27B | $10.09B | $9.93B |
| Shareholders' equity | $8.79B | $10.53B | $10.24B | $9.93B | $7.96B |
| Net debt | $2.86B | $1.63B | $1.59B | $2.63B | $3.24B |
| Cash flow statement | |||||
| Operating cash flow | $465.00M | $1.31B | $2.34B | $3.40B | $2.39B |
| Capital expenditure | $995.00M | $1.01B | $1.03B | $1.11B | $658.00M |
| Free cash flow | -$530.00M | $306.00M | $1.30B | $2.29B | $1.74B |
| Investing cash flow | -$1.22B | -$1.00B | -$1.04B | -$2.48B | -$3.21B |
| Financing cash flow | $530.00M | -$650.00M | -$245.00M | -$587.00M | $1.44B |
| Depreciation & amortization | $1.18B | $1.11B | $1.10B | $1.06B | $840.00M |
| Stock-based compensation | $41.00M | $41.00M | $43.00M | $36.00M | $31.00M |
| Dividends paid | $272.00M | $264.00M | $221.00M | $169.00M | $145.00M |
| Share buybacks | $63.00M | $60.00M | $23.00M | $101.00M | $30.00M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.